UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Double-Edged Sword of Autophagy Modulation in Cancer

Clinical cancer research, 2009-09, Vol.15 (17), p.5308-5316

2009

Volltextzugriff (PDF)

Rapid repurposing of drugs for COVID-19

Science (American Association for the Advancement of Science), 2020-05, Vol.368 (6493), p.829-830

2020

Volltextzugriff (PDF)

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

The New England journal of medicine, 2015-08, Vol.373 (8), p.737-746

2015

Volltextzugriff (PDF)

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Journal of clinical oncology, 2018-04, Vol.36 (11), p.1080-1087

2018

Volltextzugriff (PDF)

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

The Journal of clinical investigation, 2016-06, Vol.126 (6), p.2334-2340

2016

Volltextzugriff (PDF)

Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis

Genes & development, 2013-07, Vol.27 (13), p.1447-1461

2013

Volltextzugriff (PDF)

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis

Genes & development, 2011-03, Vol.25 (5), p.460-470

2011

Volltextzugriff (PDF)

Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment

Cancer prevention research (Philadelphia, Pa.), 2014-04, Vol.7 (4), p.388-397

2014

Volltextzugriff (PDF)

Metabolic catastrophe as a means to cancer cell death

Journal of cell science, 2007-02, Vol.120 (3), p.379-383

2007

Volltextzugriff (PDF)

Contemporary Risk Profile of Prostate Cancer in the United States

JNCI : Journal of the National Cancer Institute, 2009-09, Vol.101 (18), p.1280-1283

2009

Volltextzugriff (PDF)

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

JAMA internal medicine, 2014-09, Vol.174 (9), p.1460

2014

Volltextzugriff (PDF)

Impact of baseline serum IL‐8 on metastatic hormone‐sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)

The Prostate, 2020-12, Vol.80 (16), p.1429-1437

2020

Volltextzugriff (PDF)

Adult Cancer Survivors Discuss Follow-up in Primary Care: ‘Not What I Want, But Maybe What I Need’

Annals of family medicine, 2012-09, Vol.10 (5), p.418-427

2012

Volltextzugriff (PDF)

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805

Clinical cancer research, 2018-01, Vol.24 (1), p.217-223

2018

Volltextzugriff (PDF)

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

JAMA oncology, 2020-04, Vol.6 (4), p.e196496

2020

Volltextzugriff (PDF)

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers

The oncologist (Dayton, Ohio), 2016-11, Vol.21 (11), p.1315-1325

2016

Volltextzugriff (PDF)

Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2450-2456

2009

Volltextzugriff (PDF)

Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy

Scientific reports, 2015-08, Vol.5 (1), p.13390-13390, Article 13390

2015

Volltextzugriff (PDF)

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells

Oncotarget, 2015-06, Vol.6 (17), p.15321-15331

2015

Volltextzugriff (PDF)

Collaborative team dynamics and scholarly outcomes of multidisciplinary research teams: A mixed-methods approach

Journal of clinical and translational science, 2023, Vol.7 (1), p.e59, Article e59

2023

Volltextzugriff (PDF)

Precision Medicine: Implications for Science and Practice

Journal of the American College of Surgeons, 2016-09, Vol.223 (3), p.433-439.e1

2016

Volltextzugriff (PDF)

An active learning approach for rapid characterization of endothelial cells in human tumors

PloS one, 2014-03, Vol.9 (3), p.e90495-e90495

2014

Volltextzugriff (PDF)

A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer

Cancers, 2023-04, Vol.15 (9), p.2505

2023

Volltextzugriff (PDF)

Phase II Randomized Study of Vaccine Treatment of Advanced Prostate Cancer (E7897): A Trial of the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2122-2132

2004

Volltextzugriff (PDF)

1 – 25 von 400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(385)
Mit Volltextzugriff
(337)

Publikationsform

Sprache

Englisch
(391)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Double-Edged Sword of Autophagy Modulation in Cancer

Rapid repurposing of drugs for COVID-19

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis

Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment

Metabolic catastrophe as a means to cancer cell death

Contemporary Risk Profile of Prostate Cancer in the United States

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

Impact of baseline serum IL‐8 on metastatic hormone‐sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805)

Adult Cancer Survivors Discuss Follow-up in Primary Care: ‘Not What I Want, But Maybe What I Need’

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers

Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916

Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells

Collaborative team dynamics and scholarly outcomes of multidisciplinary research teams: A mixed-methods approach

Precision Medicine: Implications for Science and Practice

An active learning approach for rapid characterization of endothelial cells in human tumors

A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer

Phase II Randomized Study of Vaccine Treatment of Advanced Prostate Cancer (E7897): A Trial of the Eastern Cooperative Oncology Group

Suchergebnisse filtern